News Releases Investor Relations Investor Menu Overview Events & Presentations Upcoming Events Past Events Presentations Stock Info Stock Quote & Chart Historic Price Lookup Investment Calculator News Releases SEC Filings Analyst Coverage Governance Documents & Charters Committee Composition IR Resources Investor FAQs Email Alerts Contact IR News Releases Year: All News201920182017 Summary ToggleDova Pharmaceuticals to Present at Leerink Partners 7th Annual Global Healthcare Conference February 12, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 15, 2018 February 12, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces the Appointment of Mark W. Hahn as Chief Financial Officer January 30, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Present at J.P. Morgan Healthcare Conference January 3, 2018 View News Release > Summary ToggleDova Pharmaceuticals Provides Update on Development Strategy for Avatrombopag in Immune Thrombocytopenic Purpura (ITP) and Chemotherapy-Induced Thrombocytopenia (CIT) January 3, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces Four Presentations at the 59th American Society of Hematology Annual Meeting December 4, 2017 View News Release > Summary ToggleDova Pharmaceuticals Announces FDA Acceptance of the Avatrombopag New Drug Application (NDA) with Priority Review November 27, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at Evercore ISI Conference November 21, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at Jefferies 2017 London Healthcare Conference November 10, 2017 View News Release > Summary ToggleDova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results November 9, 2017 View News Release > Pagination First page First Previous page Previous … Page 2 Page 3 Current page 4 Page 5 Next page Next Last page Last
News Releases Year: All News201920182017 Summary ToggleDova Pharmaceuticals to Present at Leerink Partners 7th Annual Global Healthcare Conference February 12, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Announce Fourth Quarter and Full Year 2017 Financial Results on February 15, 2018 February 12, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces the Appointment of Mark W. Hahn as Chief Financial Officer January 30, 2018 View News Release > Summary ToggleDova Pharmaceuticals to Present at J.P. Morgan Healthcare Conference January 3, 2018 View News Release > Summary ToggleDova Pharmaceuticals Provides Update on Development Strategy for Avatrombopag in Immune Thrombocytopenic Purpura (ITP) and Chemotherapy-Induced Thrombocytopenia (CIT) January 3, 2018 View News Release > Summary ToggleDova Pharmaceuticals Announces Four Presentations at the 59th American Society of Hematology Annual Meeting December 4, 2017 View News Release > Summary ToggleDova Pharmaceuticals Announces FDA Acceptance of the Avatrombopag New Drug Application (NDA) with Priority Review November 27, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at Evercore ISI Conference November 21, 2017 View News Release > Summary ToggleDova Pharmaceuticals to Present at Jefferies 2017 London Healthcare Conference November 10, 2017 View News Release > Summary ToggleDova Pharmaceuticals Reports Third Quarter 2017 Operating and Financial Results November 9, 2017 View News Release > Pagination First page First Previous page Previous … Page 2 Page 3 Current page 4 Page 5 Next page Next Last page Last
